Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is an often unrecognized complication of type 2 diabetes (T2DM) associated with significant economic burden and poor long-term hepatic and extrahepatic outcomes. Our goal is to review evidence about the complex association between NAFLD and T2DM and highlight the potential for disease co-management with the available medications used for the treatment of diabetes.

Budd, J.T., Cusi, K. (2020) Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. Curr Diab Rep Volume 20, Issue 9. doi: 10.1007/s11892-020-01349-1